Description
Saxenda Weight Loss Injection – 2.4mg/0.5mL
Saxenda is the original weight loss pen which has been available in the UK since 2020. This treatment has shown that the average patient will achieve around 10% body weight loss over the course of treatment.
Saxenda 2.4mg contains the active ingredient liraglutide. This is a sister drug of semaglutide, and both belong to a group of drugs called GLP-1 agonist.
Saxenda is a very similar injection to Wegovy, except it is used once daily instead of once weekly. It works in the same way, suppressing the appetite to reduce eating to assist with losing weight. It is prescribed to patients with A BMI of over 30 or above 27.5 with additional risk factors, just like Wegovy.
Saxenda 2.4 Price (Stock Price): $270
What is the most important information I should know about Saxenda®?
Patients should follow a 4-week dose escalation to reach the clinically efficacious 3 mg dose. The 4-week dose-escalation period can reduce the likelihood of gastrointestinal symptoms.1
Serious side effects may happen in people who take Saxenda®, including:
Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Do not use Saxenda® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Who should not use Saxenda®?
Do not use Saxenda® if:
- you or any of your family have ever had MTC or if you have MEN 2
- you have had a serious allergic reaction to liraglutide or any of the ingredients in Saxenda®. See symptoms of serious allergic reactions in “What are the possible side effects of Saxenda®?”
- you are pregnant or plan to become pregnant. Saxenda® may harm your unborn baby
- Before taking Saxenda®, tell your health care provider about all of your medical conditions, including if you:
are taking certain medicines called GLP-1 receptor agonists
- have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food
- have or have had problems with your pancreas, kidneys or liver
- have or have had depression or suicidal thoughts, or mental health issues
- are breastfeeding or plan to breastfeed. It is not known if Saxenda® passes into your breast milk. You and your health care provider should decide if you will use Saxenda® or breastfeed
Saxenda 2.4 Prescription
To confirm Saxenda 2.4 dose, Read the Instructions for Use that comes with Saxenda®
Inject your dose of Saxenda® under the skin (subcutaneously) in your stomach area (abdomen), upper leg (thigh), or upper arm, as instructed by your health care provider. Do not inject into a vein or muscle
Change (rotate) your injection site within the area you choose with each injection to reduce your risk of getting lumps under the skin (cutaneous amyloidosis). Do not use the same site for each injection
Common Side Effects
The most common Saxenda 2.4 Side Effects may include:
- nausea
- vomiting
- feeling tired
- diarrhea
- constipation
- injection site reactions
- stomach (abdominal) pain
- change in enzyme (lipase) levels in your blood
You must be logged in to post a review.
Reviews
There are no reviews yet.